Chitranjan Meditech & Fragrance Private Limited
Founded in 2015 and headquartered in Bihar, India.
2015 | Patna, Bihar (India) | Active
Chitranjan Meditech & Fragrance Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Chitranjan Meditech & Fragrance
Chitranjan Meditech & Fragrance Private Limited (CMFPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2015 (Nine years and ten months 28 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Sinha and Sunil Kumar serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24240BR2015PTC023958
- Company No.
023958
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Trading
Who are the key members and board of directors at Chitranjan Meditech & Fragrance?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Sinha  | Director | 31-Mar-2015 | Current |
| Sunil Kumar | Director | 31-Mar-2015 | Current |
Financial Performance of Chitranjan Meditech & Fragrance.
Chitranjan Meditech & Fragrance Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chitranjan Meditech & Fragrance?
In 2017, Chitranjan Meditech & Fragrance had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chitranjan Meditech & Fragrance?
Chitranjan Meditech & Fragrance has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chitranjan Meditech & Fragrance, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chitranjan Meditech & Fragrance's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
